Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Azelaic acid in a special gel is more effective against skin fungi than regular azelaic acid.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

TPA is about 50 times more effective at promoting tumors than MZ.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.